PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that it has granted a stock option to a newly hired employee under the company’s 2022 Inducement Plan, as approved by the Compensation Committee of its Board of Directors.
The award, dated September 30, 2025, provides the employee the option to purchase 1,302 shares of INOVIO common stock at an exercise price of $2.34 — the closing price of the company’s stock on the grant date. The stock option will vest in three equal annual installments over a three-year period, contingent upon the employee’s continued employment with INOVIO on each vesting date.
The grant was made in accordance with Nasdaq Listing Rule 5635(c)(4), which permits equity awards to new employees as an inducement to join the company. The award is subject to the terms and conditions outlined in the stock option agreement under INOVIO’s Inducement Plan.
INOVIO, a biotechnology company headquartered in Plymouth Meeting, focuses on developing DNA medicines and immunotherapies for infectious diseases and cancer.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.